Annette Markert

500 total citations
18 papers, 431 citations indexed

About

Annette Markert is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Annette Markert has authored 18 papers receiving a total of 431 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Oncology. Recurrent topics in Annette Markert's work include Monoclonal and Polyclonal Antibodies Research (9 papers), Peptidase Inhibition and Analysis (6 papers) and Glycosylation and Glycoproteins Research (4 papers). Annette Markert is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (9 papers), Peptidase Inhibition and Analysis (6 papers) and Glycosylation and Glycoproteins Research (4 papers). Annette Markert collaborates with scholars based in Germany, France and United States. Annette Markert's co-authors include Annette Altmann, Vasileios Askoxylakis, Wolfram Zillig, Uwe Haberkorn, Walter Mier, Thomas Drepper, Karl‐Erich Jaeger, Frederic Zoller, Anita Loeschcke and Astrid Wirtz and has published in prestigious journals such as Angewandte Chemie International Edition, PLoS ONE and Oncogene.

In The Last Decade

Annette Markert

18 papers receiving 425 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Annette Markert Germany 13 324 88 86 81 74 18 431
Kayoko Nishi United States 17 609 1.9× 98 1.1× 31 0.4× 38 0.5× 147 2.0× 26 726
Jérôme Becquart France 10 484 1.5× 54 0.6× 112 1.3× 14 0.2× 62 0.8× 16 597
Karl J. Mathis United States 10 303 0.9× 63 0.7× 35 0.4× 12 0.1× 78 1.1× 17 509
Anat Shahar Israel 13 268 0.8× 21 0.2× 40 0.5× 18 0.2× 75 1.0× 25 401
Yiwei Miao United States 8 487 1.5× 107 1.2× 18 0.2× 40 0.5× 35 0.5× 8 599
Salil K. Niyogi United States 16 660 2.0× 141 1.6× 179 2.1× 83 1.0× 229 3.1× 37 899
Xian-Shu Cui United States 12 628 1.9× 93 1.1× 37 0.4× 18 0.2× 85 1.1× 16 768
Andreas Tebbe Germany 17 639 2.0× 36 0.4× 22 0.3× 89 1.1× 158 2.1× 22 755
Leanne Wybenga-Groot Canada 12 517 1.6× 38 0.4× 37 0.4× 18 0.2× 122 1.6× 18 727

Countries citing papers authored by Annette Markert

Since Specialization
Citations

This map shows the geographic impact of Annette Markert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annette Markert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annette Markert more than expected).

Fields of papers citing papers by Annette Markert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annette Markert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annette Markert. The network helps show where Annette Markert may publish in the future.

Co-authorship network of co-authors of Annette Markert

This figure shows the co-authorship network connecting the top 25 collaborators of Annette Markert. A scholar is included among the top collaborators of Annette Markert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annette Markert. Annette Markert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Zoller, Frederic, Annette Markert, Philippe Barthe, et al.. (2013). A Disulfide‐Constrained Miniprotein with Striking Tumor‐Binding Specificity Developed by Ribosome Display. Angewandte Chemie International Edition. 52(45). 11760–11764. 11 indexed citations
2.
Zoller, Frederic, Annette Markert, Philippe Barthe, et al.. (2013). A Disulfide‐Constrained Miniprotein with Striking Tumor‐Binding Specificity Developed by Ribosome Display. Angewandte Chemie. 125(45). 11976–11980. 3 indexed citations
3.
Zoller, Frederic, Annette Markert, Philippe Barthe, et al.. (2012). Combination of Phage Display and Molecular Grafting Generates Highly Specific Tumor‐Targeting Miniproteins. Angewandte Chemie International Edition. 51(52). 13136–13139. 36 indexed citations
4.
Askoxylakis, Vasileios, Annette Altmann, Annette Markert, et al.. (2012). Peptide-Based Targeting of the Platelet-Derived Growth Factor Receptor Beta. Molecular Imaging and Biology. 15(2). 212–221. 28 indexed citations
5.
Markert, Annette, et al.. (2012). A T7 RNA polymerase-based toolkit for the concerted expression of clustered genes. Journal of Biotechnology. 159(3). 162–171. 12 indexed citations
6.
Loeschcke, Anita, Annette Markert, Susanne Wilhelm, et al.. (2012). TREX: A Universal Tool for the Transfer and Expression of Biosynthetic Pathways in Bacteria. ACS Synthetic Biology. 2(1). 22–33. 60 indexed citations
7.
Markert, Annette, Annette Altmann, Walter Mier, et al.. (2012). Optimization of a Novel Peptide Ligand Targeting Human Carbonic Anhydrase IX. PLoS ONE. 7(5). e38279–e38279. 14 indexed citations
8.
Zoller, Frederic, Annette Markert, Philippe Barthe, et al.. (2012). Combination of Phage Display and Molecular Grafting Generates Highly Specific Tumor‐Targeting Miniproteins. Angewandte Chemie. 124(52). 13313–13316. 10 indexed citations
9.
Altmann, Annette, Annette Markert, Vasileios Askoxylakis, et al.. (2012). Antitumor Effects of Proteasome Inhibition in Anaplastic Thyroid Carcinoma. Journal of Nuclear Medicine. 53(11). 1764–1771. 32 indexed citations
10.
Zoller, Frederic, Annette Markert, Annette Altmann, Walter Mier, & Uwe Haberkorn. (2012). Identification of a novel anti-DLL4 cystine-knot miniprotein for tumor imaging using ribosome display technology. 53. 24–24. 1 indexed citations
11.
Markert, Annette, et al.. (2011). Biotechnology techniques for the development of new tumor specific peptides. Methods. 55(3). 215–222. 15 indexed citations
12.
Haberkorn, Uwe, Annette Markert, Walter Mier, Vasileios Askoxylakis, & Annette Altmann. (2011). Molecular imaging of tumor metabolism and apoptosis. Oncogene. 30(40). 4141–4151. 28 indexed citations
13.
Zoller, Frederic, et al.. (2011). Engineering and Functionalization of the Disulfide‐Constrained Miniprotein Min‐23 as a Scaffold for Diagnostic Application. ChemMedChem. 7(2). 237–247. 13 indexed citations
14.
Askoxylakis, Vasileios, Sabine Zitzmann-Kolbe, Frederic Zoller, et al.. (2011). Challenges in Optimizing a Prostate Carcinoma Binding Peptide, Identified through the Phage Display Technology. Molecules. 16(2). 1559–1578. 13 indexed citations
15.
Altmann, Annette, Michael Eisenhut, Ulrike Bauder‐Wüst, et al.. (2010). Therapy of thyroid carcinoma with the histone deacetylase inhibitor MS-275. European Journal of Nuclear Medicine and Molecular Imaging. 37(12). 2286–2297. 14 indexed citations
16.
Askoxylakis, Vasileios, Susanne Krämer, Ulrike Hebling, et al.. (2010). A New Peptide Ligand for Targeting Human Carbonic Anhydrase IX, Identified through the Phage Display Technology. PLoS ONE. 5(12). e15962–e15962. 28 indexed citations
17.
Katzke, Nadine, René Bergmann, Annette Markert, et al.. (2009). A novel T7 RNA polymerase dependent expression system for high-level protein production in the phototrophic bacterium Rhodobacter capsulatus. Protein Expression and Purification. 69(2). 137–146. 59 indexed citations
18.
Markert, Annette & Wolfram Zillig. (1965). Studies on the lysis of Escherichia coli C by bacteriophage φX174. Virology. 25(1). 88–97. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026